Veritable’s Allergan Inc AGN Stock Holding History

Veritable’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-20,433	Closed	-$4.34M	–	995
2014 Q4	$4.34M	Sell	20,433 -108	-0.5%	-$21.5K	0.09%	167
2014 Q3	$3.66M	Sell	20,541 -939	-4%	-$156K	0.08%	175
2014 Q2	$3.63M	Sell	21,480 -3,638	-14%	-$566K	0.08%	176
2014 Q1	$3.12M	Sell	25,118 -243	-1%	-$29.6K	0.07%	191
2013 Q4	$2.82M	Sell	25,361 -9,745	-28%	-$931K	0.06%	198
2013 Q3	$3.17M	Sell	35,106 -34,623	-50%	-$3.11M	0.07%	178
2013 Q2	$5.87M	Buy	+69,729	New	+$7.23M	0.14%	119

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Veritable's AGN Position: Q1 2015 in Review

Veritable sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 20,433 shares — an estimated $4.34M sold.

Veritable first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $5.87M in Q2 2013. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

Veritable reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
Veritable sold 20,433 Allergan Inc shares in Q1 2015, an estimated $4.34M.
Veritable first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
Veritable's Allergan Inc position peaked at $5.87M in Q2 2013.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Veritable's 13F filing for Q1 2015, filed 15 May 2015.